Clinical Trials

Prostate tumor ablation

Displaying 4 studies

A Study to Evaluate Software On Cross-sectional Imaging Evaluation of Microwave-ablated Liver Tumors Rochester, MN

The primary purpose of this study is to assess the accuracy of the Philips High Precision 3D Ablation Solution software on cross-sectional imaging evaluation of microwave-ablated liver tumors, and to determine whether software accuracy varies based on patient, tumor, and technical procedural factors.
Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue Rochester, MN

The purpose of this study is to determine the safety of the NanoKnife treatment in prostate cancer tissue when used in a low and intermediate risk patient population.
Focal Prostate Ablation Utilizing TULSA Profound System Rochester, MN

The primary hypotheses are that the TULSA-Procedure is safe and effective treatment of intermediate grade prostate cancer over 2 years. The primary endpoint is defined as the proportion of patients who maintain urinary continence and erectile potency. The effectiveness co-primary endpoint is defined as the proportion of patients free from treatment failure.
Study of NanoKnife for Ablation of Prostate Cancer in Low and Intermediate Risk Patients Rochester, MN

The purpose of this study is to determine the safety of the NanoKnife treatment in prostate cancer tissue when used in a low and intermediate risk patient population.